Use access key #2 to skip to page content.

Dividends4Life (25.50)

Amgen, Inc. (AMGN) Dividend Stock Analysis



March 15, 2018 – Comments (0) | RELATED TICKERS: AMGN , BIIB , CELG

Linked here is a detailed quantitative analysis of Amgen, Inc. (AMGN). Below are some highlights from the above linked analysis:

Company Description: Amgen Inc. is one of the world's leading biotech companies with major treatments for anemia, neutropenia, rheumatoid and psoriatic arthritis, psoriasis, cancer and osteoporosis.

Continue Reading »

0 Comments – Post Your Own

Featured Broker Partners